To explore the relationship among psychoneurological symptom cluster (PNSC) in breast cancer patients and identify potential intervention targets.
Approach:
Study Design: Cross-sectional study involving 304 breast cancer patients who received treatment.
Data Collection: Self-report data collected using the Cancer Fatigue Scale, Pittsburgh Sleep Quality Index, Hospital Anxiety and Depression Scale, and Visual Analog Scale for Pain.
Network Analysis: Static interrelationships examined using Gaussian network model; directional associations explored with Bayesian network analysis.
Simulated Interventions: Dynamic correspondence between symptoms assessed through computer-simulated interventions.
Key Findings:
Physical fatigue, sleep latency, and depression identified as core symptoms with expected influence values of 1.883, 0.940, and 0.794, respectively.
Physical fatigue, pain, and daytime dysfunction recognized as bridging symptoms with bridge expected influence values of 1.824, 1.558, and 1.331, respectively.
Depression showed the largest reduction in simulated interventions, with sum scores declining from 5.98 to 4.67, followed by affective fatigue and physical fatigue.
Interpretation:
Physical fatigue and depression may be prioritized as intervention targets to disrupt symptom interactions within the PNSC.
Limitations:
Study conducted within a specific time frame and location, which may limit the generalizability of the findings.
Further research is needed to verify the effectiveness of targeting identified symptoms.
Conclusion:
Integration of computer-simulated interventions with network analysis provides insights into symptom interactions and potential intervention targets.
Harold Burstein, MD, PhD, and Ana C. Garrido-Castro, MD discuss results from the Pumitamig + DB-1305/BNT325 trial, which were presented at the 2026 ESMO Breast Cancer Congress.